March 9, 2007 -- A new analysis that compared 3 common treatment options for prostate cancer found a difference between them. Men who were treated with external-beam radiotherapy did not live as long ...
Contemporary post-prostatectomy radiation therapy for prostate cancer within a statewide quality consortium. AI-driven prediction of prostate cancer risk: A comparative analysis with C the Signs in ...
Johnson & Johnson (NYSE:JNJ) has entered a clinical supply agreement with GI Innovation to test a bispecific immunotherapy ...
At the recent American Urological Association (AUA) annual meeting, focal therapies for localized prostate cancer took center stage, moving from a niche option to a recognized alternative to surgery ...
MedPage Today on MSN
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer
But does it cost too much?
As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...
Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.
SEOUL, South Korea, March 19, 2026 /PRNewswire/ -- GI Innovation announced on 19th that it has entered into a clinical supply agreement with Johnson & Johnson to evaluate a combination therapy in ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results